SUMMIT Study Shows Off Power Of Mass Cancer Screening
Executive Summary
SUMMIT, the landmark study conducted within the UK focused on diagnosing lung cancer before it becomes untreatable, has demonstrated the practicality and cost effectiveness of mass CT screening.
You may also be interested in...
Start-Up Spotlight: Allelica Offers Personalized Medicine Via Genomic Sequencing
Allelica, a company specializing in diagnostics "software as a service," has obtained $1.75m in seed funding to bring genomic risk prediction to the forefront of patient care.
Medical Imaging Disruptor Nano-X Pushes On With Launch Plans In Face Of Shareholder Lawsuit
Nano-X Imaging is on a mission to disrupt the market for X-ray imaging equipment by offering a low-cost medical imaging service to untapped markets through a network of equipment dotted around the world. However, some shareholders are claiming the company mislead investors.
Moving Pharma Execs Out Of The Shadows Is Key To Building Public Trust
2024 Rising Leader, Jack O’Meara, says the industry must ‘promote personalities’ when building new biotech businesses to gain the trust of investors and the public.